Three healthcare businesses, ready to launch.
Research supply, telehealth, and a 503B provider network — each built and run end-to-end. Here are the opportunities, the economics, and the investment to get each one up and running.
Three revenue lanes
Built & run by Health RailsTested & documented
Third-party lab testing with matching COAs on every research lot.
Compliant by design
Each business is a separate entity with its own accounts and regulatory posture.
Live from day one
Turnkey storefront, payments, and fulfillment — ready to sell immediately.
Three Options
Three ways into the market
Each is a separate business with its own brand, entity, and accounts — built and operated end-to-end.
The Numbers, Side by Side
Three lanes, three economic profiles
| Lane | To launch | Margin profile | Revenue shape |
|---|---|---|---|
| Research-Only Supply | ~$400k supply | Owned supply chain | Pharma-grade · ~$20–30k per SKU |
| Telehealth (3 brands) | $120k | ~70–77% gross | Recurring · $1,000–1,800 LTV |
| 503B Provider Network | Scoped / launch | ~40% → ~70% w/ own API | Bulk B2B · recurring reorders |
Working ranges, scoped per engagement. Full economics on each option's page.
The Partnership
What it takes to launch each
Research-Only
~$400k controlled supply
US pharma-grade controlled peptides — own API + controlled US compounding + brand. ~$20–30k per SKU.
Telehealth
$120k for 3 brands
Premium men's, premium women's & value weight-loss — fully built on one backend · ~70% margins · ~$1,000–1,800 LTV per client.
503B Network
Scoped per launch
Registered-facility partnership + clinic onboarding; recurring B2B accounts.
launches all three telehealth brands
Premium men's, premium women's & a value weight-loss brand — fully built. Research-only is its own controlled supply; 503B scoped per launch.